Roles of LPA receptor-mediated signaling in tumor promotion by long-term tamoxifen treatment in breast cancer cells

被引：0
|
作者：
Takai, Miwa [1 ]
Yamamoto, Mao [1 ]
Yashiro, Narumi [1 ]
Ikeda, Hiroko [1 ]
Tsujiuchi, Toshifumi [1 ]
机构：
[1] Kindai Univ, Mol Oncol Life Sci, Osaka, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-1248
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [21] The tumour microenvironment influences long-term tamoxifen treatment response in breast cancer patients
    Romera, P. Camargo
    Romero, M. Rios
    Danielsson, O.
    Dar, H. Akhtar
    Lindstrom, L. S.
    Tobin, N. P.
    ANNALS OF ONCOLOGY, 2024, 35 : S327 - S327
  • [22] LONG-TERM TAMOXIFEN TREATMENT OF ATHYMIC MICE IMPLANTED WITH MCF-7 BREAST-CANCER CELLS - CRITICAL IMPORTANCE OF TUMOR BURDEN
    GOTTARDIS, MM
    JORDAN, VC
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 85 - 85
  • [23] Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer
    Boele, Florien W.
    Schilder, Christina M. T.
    de Roode, Mari-Lou
    Deijen, Jan Berend
    Schagen, Sanne B.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (01): : 17 - 25
  • [24] EFFECT OF LONG-TERM TAMOXIFEN TREATMENT ON BONE TURNOVER IN WOMEN WITH BREAST-CANCER
    WRIGHT, CDP
    MANSELL, RE
    GAZET, JC
    COMPSTON, JE
    BRITISH MEDICAL JOURNAL, 1993, 306 (6875): : 429 - 430
  • [25] CHEMOSUPPRESSION OF BREAST-CANCER WITH LONG-TERM TAMOXIFEN THERAPY
    JORDAN, VC
    PREVENTIVE MEDICINE, 1991, 20 (01) : 3 - 14
  • [26] LONG-TERM ADJUVANT TAMOXIFEN THERAPY FOR BREAST-CANCER
    JORDAN, VC
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 15 (03) : 125 - 136
  • [27] Long-term depression of kainate receptor-mediated synaptic transmission
    Park, YY
    Jo, J
    Isaac, JTR
    Cho, K
    NEURON, 2006, 49 (01) : 95 - 106
  • [28] CHEMOSUPPRESSION OF BREAST-CANCER BY LONG-TERM THERAPY WITH TAMOXIFEN
    JORDAN, VC
    CANCER AND METASTASIS REVIEWS, 1989, 8 (02) : 188 - 188
  • [29] Progesterone receptor positivity is an independent predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
    Fohlin, H.
    Nordenskjold, A.
    Fornander, T.
    Lofdahl, B.
    Skoog, L.
    Stal, O.
    CANCER RESEARCH, 2016, 76
  • [30] LONG-TERM ADJUVANT THERAPY WITH TAMOXIFEN IN BREAST-CANCER - HOW LONG IS LONG
    TORMEY, DC
    ANNALS OF INTERNAL MEDICINE, 1987, 106 (05) : 762 - 764
12345